合成原料的适应 Pseudomonas putida 的一个非本地基质 D-xylose
Pavel Dvořák1, Barbora Burýšková2, Barbora Popelářová2
1Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 753/5, 62500, Brno, Czech Republic. pdvorak@sci.muni.cz.
Nature communications
|March 27, 2024
概括
这项研究设计了Pseudomonas putida以使用D-xylose,一种可再生糖. 适应性实验室进化 (ALE) 揭示了关键的代谢适应,增强酶表达和糖解,以有效利用糖.
科学领域:
- 代谢工程是代谢工程.
- 合成生物学 合成生物学
- 微生物生物技术 微生物生物技术
背景情况:
- 微生物细胞工厂对于利用可再生基质至关重要.
- 了解适应非原生基质的理解需要进行整体研究.
- Pseudomonas putida 是为了利用 D-糖而设计的,但代谢同化途径尚不清楚.
研究的目的:
- 为了阐明工程化Pseudomonas putida中的D-西洛斯代谢.
- 为进一步的代谢工程和适应性实验室进化 (ALE) 奠定基础.
- 了解细菌适应非原生碳来源的机制.
主要方法:
- 合理的基因工程的伪omonas putida.
- 删除hexR基因以消除原生糖解.
- 引入外源性转基因酶和转基因酶基因.
- 适应性实验室进化 (ALE) 优化新陈代谢.
- 多层次分析和逆向工程.
主要成果:
- 成功设计了Pseudomonas putida的D-xylose同化方法.
- 在ALE期间识别关键的适应事件.
- 增强了跨阿尔多酶和西洛异相酶的表达.
- 作为一个关键的适应,糖解的减压.
结论:
- 获得了对与非本土碳来源平行适应路径的详细见解.
- 这项研究为先进的代谢工程和ALE策略提供了基础.
- 在Pseudomonas putida中实现了优化D-基酸代谢.
更多相关视频
14:53Techniques for the Evolution of Robust Pentose-fermenting Yeast for Bioconversion of Lignocellulose to Ethanol
Published on: October 24, 2016
11.2K
06:53In Vivo Monitoring of Transcriptional Activity During Metabolic Transition Using a Bioluminescent Reporter in Yeast
Published on: February 21, 2025
375
相关概念视频
Biosynthesis of Polysaccharides
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
